
Coherus BioSciences CHRS
€ 1.38
-5.03%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Coherus BioSciences EV/EBITDA 2011-2026 | CHRS
EV/EBITDA Jährlich Coherus BioSciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.11 | 7.67 | 11.6 | -4.38 | -2.44 | -10.2 | -1.54 | -0.52 | 0.738 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 11.6 | -10.2 | -0.351 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Adagene
ADAG
|
-4.92 | $ 1.65 | 7.91 % | $ 92.9 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.59 | 1.99 % | $ 8.64 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-30.8 | $ 66.05 | 2.3 % | $ 8.83 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.38 | $ 1.52 | -16.3 % | $ 388 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Biogen
BIIB
|
12.7 | $ 184.48 | -1.67 % | $ 26.9 B | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
BioNTech SE
BNTX
|
4.1 | $ 102.17 | 2.32 % | $ 27.2 B | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | $ 93.52 | -1.2 % | $ 96.9 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-43.1 | $ 4.25 | 1.67 % | $ 9.25 B | ||
|
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-16.9 | - | -7.31 % | $ 87 M | ||
|
Bristol-Myers Squibb Company
BMY
|
19.7 | $ 55.71 | -0.28 % | $ 113 B | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-15.7 | $ 207.49 | 2.22 % | $ 5 B | ||
|
Codiak BioSciences
CDAK
|
-4.38 | - | -55.98 % | $ 2.15 M | ||
|
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M | ||
|
Cerevel Therapeutics Holdings
CERE
|
-19.7 | - | - | $ 7.29 B | ||
|
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M | ||
|
Zai Lab Limited
ZLAB
|
-6.18 | $ 18.37 | -0.97 % | $ 18.2 B | ||
|
Catalyst Biosciences
CBIO
|
0.34 | $ 10.84 | 0.46 % | $ 714 M | ||
|
Caladrius Biosciences
CLBS
|
0.677 | - | -16.75 % | $ 25.8 M | ||
|
Celldex Therapeutics
CLDX
|
0.185 | $ 25.59 | -6.54 % | $ 1.65 M | ||
|
Cellectis S.A.
CLLS
|
-1.37 | $ 4.22 | -4.2 % | $ 116 M | ||
|
Clearside Biomedical
CLSD
|
-73.5 | - | - | $ 25.3 M | ||
|
Chimerix
CMRX
|
-3.04 | - | - | $ 756 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-12.7 | - | -15.15 % | $ 60.3 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
17.3 | $ 37.35 | -0.4 % | $ 3.86 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
7.16 | $ 23.18 | 2.02 % | $ 2.75 B | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-8.38 | $ 55.11 | 3.49 % | $ 4.45 B | ||
|
CRISPR Therapeutics AG
CRSP
|
13.1 | $ 55.17 | 2.47 % | $ 4.65 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
Zentalis Pharmaceuticals
ZNTL
|
-16.7 | $ 3.53 | -5.75 % | $ 231 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
17.3 | $ 29.43 | 6.09 % | $ 1.43 B |